|
Garcia-Alvarez L, Garcia-Garcia C, Munoz P, Farinas-Alvarez MDC, Cuadra MG, Fernandez-Hidalgo N, Garcia-Vazquez E, Moral-Escudero E, Alonso-Socas MDM, Garcia-Rosado D, Hidalgo-Tenorio C, Dominguez F, Goikoetxea-Agirre J, Gainzarain JC, Rodriguez-Esteban MA, Bosch-Guerra X, Oteo JA, On Behalf Of Grupo de Apoyo Al Manejo de la Endocarditis Infecciosa En Espana Games. Bartonella Endocarditis in Spain: Case Reports of 21 Cases. Pathogens. 2022 May 10;11(5):561. doi: 10.3390/pathogens11050561. PubMed PMID: 35631082; PubMed Central PMCID: PMC9143151.
AÑO: 2022; IF: 4.531
|
|
Vicent L, Goenaga MA, Munoz P, Marin-Arriaza M, Valerio M, Farinas MC, Cobo-Belaustegui M, de Alarcon A, Rodriguez-Esteban MA, Miro JM, Goikoetxea-Agirre AJ, de Castro Campos D, Garcia-Vazquez E, Martinez-Selles M; GAMEs investigators. Infective endocarditis in children and adolescents: a different profile with clinical implications. Pediatr Res. 2022 Nov;92(5):1400-1406. doi: 10.1038/s41390-022-01959-3. Epub 2022 Feb 11. PubMed PMID: 35149848.
AÑO: 2022; IF: 3.6
|
|
Ros-Lucas JA, Pascual-Figal DA, Noguera-Velasco JA, Hernandez-Vicente A, Cebreiros-Lopez I, Arnaldos-Carrillo M, Martinez-Ardil IM, Garcia-Vazquez E, Aparicio-Vicente M, Solana-Martinez E, Ruiz-Martinez SY, Fernandez-Mula L, Andujar-Espinosa R, Fernandez-Suarez B, Sanchez-Caro MD, Penalver-Mellado C, Ruiz-Lopez FJ. CA 15-3 prognostic biomarker in SARS-CoV-2 pneumonia. Sci Rep. 2022 Apr 25;12(1):6738. doi: 10.1038/s41598-022-10726-7. PubMed PMID: 35469047; PubMed Central PMCID: PMC9037059.
AÑO: 2022; IF: 4.6
|
|
Alvarez-Zaballos S, Gonzalez-Ramallo V, Quintana E, Munoz P, de la Villa-Martinez S, Farinas MC, Arnaiz-de Las Revillas F, de Alarcon A, Rodriguez-Esteban MA, Miro JM, Goenaga MA, Goikoetxea-Agirre J, Garcia-Vazquez E, Boix-Palop L, Martinez-Selles M, On Behalf Of Games. Multivalvular Endocarditis: A Rare Condition with Poor Prognosis. J Clin Med. 2022 Aug 13;11(16):4736. doi: 10.3390/jcm11164736. PubMed PMID: 36012974; PubMed Central PMCID: PMC9410199.
AÑO: 2022; IF: 4.964
|
|
Sanchez Barrueco A, Mateos-Moreno MV, Martinez-Beneyto Y, Garcia-Vazquez E, Campos Gonzalez A, Zapardiel Ferrero J, Bogoya Castano A, Alcala Rueda I, Villacampa Auba JM, Cenjor Espanol C, Moreno-Parrado L, Ausina-Marquez V, Garcia-Esteban S, Artacho A, Lopez-Labrador FX, Mira A, Ferrer MD. Effect of oral antiseptics in reducing SARS-CoV-2 infectivity: evidence from a randomized double-blind clinical trial. Emerg Microbes Infect. 2022 Dec;11(1):1833-1842. doi: 10.1080/22221751.2022.2098059. PubMed PMID: 35796097; PubMed Central PMCID: PMC9336498.
AÑO: 2022; IF: 13.2
|
35631082